Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05174026
What this trial is testing

18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery

Who this might be right for
Metastatic Malignant NeoplasmMetastatic Malignant Neoplasm in the Bone
M.D. Anderson Cancer Center 10
Early research (Phase 1)Looking for participantsNCT07705035
What this trial is testing

DBC-664 in Adult Patients With Solid Tumors

Who this might be right for
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma+3 more
Duboce Biopharmaceuticals, Inc. 210
Early research (Phase 1)Looking for participantsNCT07224425
What this trial is testing

BI 3810944 in Patients With Advanced Cancer

Who this might be right for
Solid TumoursMelanoma
Boehringer Ingelheim 69
Testing effectiveness (Phase 2)UnknownNCT04462809
What this trial is testing

Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma

Who this might be right for
Advanced Malignant Pleural or Peritoneal Mesothelioma
Hospices Civils de Lyon 40
Not applicableLooking for participantsNCT07510321
What this trial is testing

FL-261 Imaging for Cancer Diagnosis and Staging

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerHead & Neck Cancer+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Early research (Phase 1)UnknownNCT05277454
What this trial is testing

Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT

Who this might be right for
Advanced Malignant Solid TumorsTGCT
Hutchison Medipharma Limited 113
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Early research (Phase 1)Active Not RecruitingNCT05914376
What this trial is testing

Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

Who this might be right for
Advanced Solid Tumors
Hangzhou Converd Co., Ltd. 24
Early research (Phase 1)Ended earlyNCT04729725
What this trial is testing

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT04980690
What this trial is testing

Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd. 228
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123
What this trial is testing

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT06682780
What this trial is testing

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Limited 320
Early research (Phase 1)Active Not RecruitingNCT04111458
What this trial is testing

Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)

Who this might be right for
Solid Tumors, KRAS Mutation; SOS1
Boehringer Ingelheim 71
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Early research (Phase 1)Study completedNCT02273388
What this trial is testing

BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 65
Testing effectiveness (Phase 2)UnknownNCT00030459
What this trial is testing

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
British Thoracic Society
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Very early researchLooking for participantsNCT05141474
What this trial is testing

Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors

Who this might be right for
Epithelial Tumors, MalignantMalignant Solid Tumor
Vall d'Hebron Institute of Oncology 10
Early research (Phase 1)Looking for participantsNCT06606990
What this trial is testing

Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

Who this might be right for
Metastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 40
Next Page